Demethylbellidifolin isolated from Swertia bimaculate against human carboxylesterase 2: Kinetics and interaction mechanism merged with docking simulations

Bioorg Chem. 2019 Sep:90:103101. doi: 10.1016/j.bioorg.2019.103101. Epub 2019 Jul 3.

Abstract

In this study, forty-nine kinds of traditional Chinese medicines (TCMs) were evaluated for their inhibitory activities against human carboxylesterase 2 (HCE 2) using a human liver microsome (HLM) system. Swertia bimaculata showed significant inhibition on HCE 2 at 10 μg/mL among forty-nine kinds of TCMs. The extract of Swertia bimaculata was separated by preparative HPLC to afford demethylbellidifolin (1) identified by MS, 1H NMR, and 13C NMR spectra. Demethylbellidifolin (1) was assayed for its inhibitory HCE 2 effect by HCE 2-mediated DDAB hydrolysis, and its potential IC50 value was 3.12 ± 0.64 μM. Demethylbellidifolin (1) was assigned as a mixed-type competitive inhibitor with the inhibiton constant Ki value of 6.87 µM by Lineweaver-Burk and slope plots. Living cell imaging was conducted to corroborate its inhibitory HCE 2 activity. Molecular docking indicated potential interactions of demethylbellidifolin (1) with HCE 2 through two hydrogen bonds of the C-3 and C-5 hydroxy groups with amino acid residues Glu227 and Ser228 in the catalytic cavity, respectively.

Keywords: HCE 2; Inhibitor; Molecular docking; Traditional Chinese medicines.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Carboxylesterase / antagonists & inhibitors*
  • Carboxylesterase / metabolism
  • Humans
  • Hydrolysis
  • Microsomes, Liver / drug effects*
  • Microsomes, Liver / enzymology
  • Molecular Docking Simulation*
  • Molecular Structure
  • Plant Extracts / pharmacology*
  • Swertia / chemistry*
  • Xanthenes / isolation & purification*
  • Xanthenes / pharmacology*

Substances

  • Plant Extracts
  • Xanthenes
  • demethylbellidifolin
  • CES2 protein, human
  • Carboxylesterase